Related Experiment Video
Updated: Jan 22, 2026
07:33
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
37.2K
New developments in pharmacotherapy for Friedreich ataxia
Alexandra Clay1, Patrick Hearle1, Kim Schadt1
1Division of Neurology, Children's Hospital of Philadelphia , Philadelphia , PA , USA.
Expert Opinion on Pharmacotherapy
|July 18, 2019
Summary
Friedreich ataxia (FRDA) treatments aim to improve mitochondrial function and alleviate symptoms. Potential cures for this rare disease may involve combination therapies or drugs that restore frataxin levels.
Area of Science:
- Neurogenetics
- Mitochondrial Biology
- Rare Diseases
Background:
- Friedreich ataxia (FRDA) is a rare genetic disorder affecting approximately 1 in 50,000 individuals.
- It is caused by a deficiency in the mitochondrial protein frataxin, leading to complex multisystemic effects.
- Current therapeutic strategies focus on mitigating the consequences of frataxin deficiency.
Purpose of the Study:
- To review current and past research on Friedreich ataxia (FRDA) treatments.
- To analyze the future implications of various therapeutic approaches for FRDA.
- To discuss the potential for curative treatments for FRDA.
Main Methods:
- Comprehensive review of in vivo and in vitro research studies on FRDA treatments.
- Analysis of data from ongoing and completed clinical trials.
- Synthesis of expert opinions on the efficacy and potential of different therapeutic strategies.
Main Results:
- Multiple clinical trials have been conducted for FRDA, focusing on mitochondrial augmentation and symptom alleviation.
- Existing therapies are not considered cures but aim to manage the disease's impact.
- Research is rapidly advancing for this rare disease.
Conclusions:
- Current FRDA therapies aim to improve mitochondrial function and reduce symptoms.
- Potential cures for FRDA are more likely to involve combination therapies or drugs that directly increase frataxin levels.
- Further research is crucial for developing effective treatments and cures for Friedreich ataxia.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
480
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
480
01:15Diabetes: Management and Pharmacotherapy
878
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
878
01:43Sustainable Development
14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
01:15Development of the Lymphatic System
2.0K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.0K
01:22Language Development
872
Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
872
01:27Development of the Heart
2.2K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.2K